CNBC's Jim Cramer reports on the latest news regarding Moderna. This Insane Timelapse From Hubble Will Change Your ...

Jim Cramer in a latest program on CNBC made the case for investing in individual stocks to enjoy bigger gains when compared ...

CNBC’s Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, ...

CNBC’s Jim Cramer previews key earnings reports and investor days that could trigger Wall Street action for the week of ...

CNBC’s Jim Cramer on Thursday named sectors that have seen major gains recently and warned investors not to buy them while ...

CNBC’s Jim Cramer on Wednesday told investors why Donald Trump’s administration might not be as friendly to big business as ...

CNBC's Jim Cramer said the Trump-fueled rally has taken a breather as Wall Street weighs what broad tax cuts could mean for ...

CNBC’s Jim Cramer on Wednesday told investors the Trump administration is more likely to allow mergers and acquisitions to go ...

CNBC's Jim Cramer said drug and junk food industries aren't necessarily headed for ruin if vaccine skeptic Robert F. Kennedy Jr. leads HHS. "Ultimately, if RFK dons jackboots and demands that we ...

Altria Group is "undervalued," Cramer says. On Oct. 31, the company reported third-quarter adjusted earnings per share of ...

Jim Cramer, the host of CNBC’s “Mad Money,” lauded Salesforce.com Inc. (NYSE:CRM) for its innovative artificial intelligence ...

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Microsoft Corporation MSFT. On Oct. 30, Microsoft ...